ADCT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.84

Margin Of Safety %

Put/Call OI Ratio

0.09

EPS Next Q Diff

-0.01

EPS Last/This Y

0.27

EPS This/Next Y

0.23

Price

3.44

Target Price

8.2

Analyst Recom

Performance Q

-11.92

Upside

-1,171.4%

Beta

1.82

Ticker: ADCT

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	ADCT	3.81	0.04	0.02	3126
2026-04-14	ADCT	3.85	0.04	0.00	3177
2026-04-15	ADCT	4.37	0.04	0.30	3243
2026-04-20	ADCT	4.26	0.03	0.61	2719
2026-04-23	ADCT	3.97	0.05	0.00	2819
2026-04-24	ADCT	3.94	0.04	0.00	2942
2026-04-27	ADCT	3.77	0.04	0.00	2953
2026-04-28	ADCT	3.78	0.04	0.00	2968
2026-04-29	ADCT	3.79	0.04	0.00	2968
2026-04-30	ADCT	3.78	0.04	124.00	3039
2026-05-01	ADCT	3.83	0.08	0.19	3162
2026-05-04	ADCT	3.67	0.09	0.11	3226
2026-05-05	ADCT	3.76	0.09	0.08	3234
2026-05-06	ADCT	3.86	0.09	0.00	3297
2026-05-07	ADCT	3.76	0.09	0.00	3296
2026-05-08	ADCT	3.5	0.09	0.36	3298
2026-05-11	ADCT	3.47	0.09	0.05	3318
2026-05-12	ADCT	3.43	0.09	0.01	3331
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	ADCT	3.82	-	-	-0.80
2026-04-14	ADCT	3.85	-	-	-0.80
2026-04-15	ADCT	4.36	-	-	-0.80
2026-04-16	ADCT	4.39	-	-	-0.80
2026-04-17	ADCT	4.29	-	-	-0.80
2026-04-20	ADCT	4.25	-	-	-0.80
2026-04-21	ADCT	4.09	-	-	-0.80
2026-04-22	ADCT	4.10	-	-	-0.80
2026-04-23	ADCT	3.97	-	-	-0.80
2026-04-24	ADCT	3.95	-	-	-0.80
2026-04-27	ADCT	3.76	-	-	-0.80
2026-04-28	ADCT	3.78	-	-	-0.80
2026-04-30	ADCT	3.78	-	-	-0.80
2026-05-01	ADCT	3.83	-	-	-0.80
2026-05-04	ADCT	3.67	-	-	-0.80
2026-05-05	ADCT	3.76	-	-	-0.80
2026-05-06	ADCT	3.86	-	-	-0.80
2026-05-07	ADCT	3.76	-	-	-0.86
2026-05-08	ADCT	3.50	-	-	-0.86
2026-05-11	ADCT	3.48	-	-	-0.85
2026-05-12	ADCT	3.44	-	-	-0.85
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-13	ADCT	-14.62	3.60	5.29
2026-04-14	ADCT	-14.62	3.60	5.29
2026-04-15	ADCT	-14.63	3.60	5.29
2026-04-16	ADCT	-14.63	3.60	5.29
2026-04-17	ADCT	-14.63	3.60	5.29
2026-04-20	ADCT	-14.63	3.57	5.29
2026-04-21	ADCT	-14.63	3.57	5.29
2026-04-22	ADCT	-14.63	3.57	5.29
2026-04-23	ADCT	-14.61	3.57	5.23
2026-04-24	ADCT	-14.93	3.57	5.23
2026-04-27	ADCT	-14.93	3.60	5.49
2026-04-28	ADCT	-14.93	3.60	5.49
2026-04-29	ADCT	-14.93	3.60	5.49
2026-04-30	ADCT	-14.93	3.60	5.49
2026-05-01	ADCT	-14.93	3.60	5.49
2026-05-04	ADCT	-14.93	3.24	5.49
2026-05-05	ADCT	-14.93	3.24	5.49
2026-05-06	ADCT	-14.93	3.24	5.49
2026-05-07	ADCT	-14.93	3.24	5.49
2026-05-08	ADCT	-14.93	3.24	5.49
2026-05-11	ADCT	-14.93	3.23	5.49
2026-05-12	ADCT	-14.93	3.23	5.84
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.21

Avg. EPS Est. Next Quarter

-0.22

Insider Transactions

-14.93

Institutional Transactions

3.23

Beta

1.82

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

89.3

Max Drawdown 5-Year %

-98.5

Target Price

8.2

P/E

Forward P/E

PEG

P/S

5.52

P/B

P/Free Cash Flow

EPS

-1.05

Average EPS Est. Cur. Y

-0.85

EPS Next Y. (Est.)

-0.62

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-173.02

Relative Volume

1.19

Return on Equity vs Sector %

36.5

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

◆ ADCT Healthcare

$3.43

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

21/25

Volume

4/15

Valuation

10/20

TP/AR

2/10

Options

7/10

RSI

34.2

Range 1M

4.5%

Sup Dist

1.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

15/25

Growth

18/30

Estimates

2/20

Inst/Vol

7/15

Options

10/10

EPS Yr

24.1%

EPS NY

27.3%

52W%

58.3%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +139.1% upside

Quality

7/30

Valuation

16/30

Growth

14/25

Stability

7/10

LT Trend

3/5

Upside

+139.1%

Quality

ADC Therapeutics SA

Sector: Healthcare

Industry: Biotechnology

Employees: 188

ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration, conditional approval from the European Commission, and conditional approval from the China National Medical Products Administration for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy. The company is also seeking to continue expanding ZYNLONTA into international markets and into earlier lines of DLBCL and indolent lymphomas, including follicular lymphoma (FL) and marginal zone lymphoma (MZL) as a single agent and in combination through its LOTIS-5 confirmatory Phase 3 clinical trial and LOTIS-7 Phase 1b clinical trial, as well as through investigator-initiated trials (IITs). In addition, it is investigating a CD-22 targeted compound' and ADCT-602 that is in a Phase 1/2 IIT in refractory B-cell acute lymphoblastic leukemia. Further, the company's pre-clinical stage pipeline includes a portfolio of next generation investigational ADCs targeting Claudin-6, NaPi2b, PSMA, NaPi2b, and ASCT2. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.

ADCT

Latest News

—

Caricamento notizie per ADCT…

stock quote shares ADCT – Adc Therapeutics SA Stock Price stock today

news today ADCT – Adc Therapeutics SA stock forecast ,stock prediction 2023 2024 2025

marketwatch ADCT – Adc Therapeutics SA yahoo finance google finance

stock history ADCT – Adc Therapeutics SA invest stock market

stock prices ADCT premarket after hours

ticker ADCT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ADCT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y